Population Screening Act: first trimester scan for prenatal screening
Health Council of the Netherlands
            Record ID 32015000610
            English
                                                            
                Authors' recommendations:
                In this advisory report the Committee on Population Screening of the Health Council of the Netherlands appraised a license application of the University Medical Centre in Groningen for a scientific study concerning the value of prenatal screening on congenital foetal defects with a so-called first-trimester anomaly scan. The minister asked the Health Council for advice concerning this study on 11 July 2014. Since 2007 all pregnant women get an offer to screen for foetal anomalies with an ultrasound at twenty weeks pregnancy (i.e. a secondtrimester anomaly scan). The scan around twenty weeks leaves the pregnant woman little time for decisions concerning the pregnancy, because after week 24 of the pregnancy the pregnancy can only be terminated if the foetus is not viable or if there is a life threatening situation for the pregnant women. The license application concerns a study into the first-trimester anomaly scan around week 13 of the pregnancy. The first-trimester anomaly scan provides pregnant women with more time for difficult decisions concerning the pregnancy if foetal defects are indeed found. Therefore the committee finds that the research in this
application is important for public health and science.
The Committee appraised the study by evaluating the legal requirements concerning the scientific soundness, actions in accordance with the relevant laws and the benefit-harm ratio. It was decided that the requirements of the Screening Act were met and the Committee advices the minister to grant the requested license. It is important that the pregnant women are informed well about the difference between participation in the scientific study and in the usual second-trimester anomaly scan. It is also important to stress the scientific importance that the anomalies detected during the first and second trimester scans are verified or falsified
by adequate diagnostic work-up during or after pregnancy, under the condition that consent of the pregnant women is obtained.
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2014
            
                                    
                URL for published report:
                http://www.gr.nl/sites/default/files/summary_201431wbo_prenatale_screening_met_een_dertienwekenecho.pdf
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                Netherlands
            
                                                
                        MeSH Terms
            - Down Syndrome
- Genetic Testing
- Pregnancy
- Prenatal Diagnosis
- Pregnancy Trimester, First
- Nuchal Translucency Measurement
- Ultrasonography
Contact
                        
                Organisation Name:
                Health Council of the Netherlands Gezondheidsraad
            
            
                        
                Contact Address:
                Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340 7520;Fax: +31 70 340 7523
            
                                    
                Contact Name:
                info@gr.nl
            
                                    
                Contact Email:
                info@gr.nl
            
                                    
                Copyright:
                Health Council of the Netherlands
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.